MetLife, Inc. (NYSE:MET) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of MetLife, Inc. (NYSE:METGet Free Report) have earned an average rating of “Moderate Buy” from the thirteen brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $79.23.

Several brokerages recently issued reports on MET. UBS Group decreased their price target on MetLife from $87.00 to $82.00 and set a “buy” rating for the company in a report on Monday, February 5th. Morgan Stanley raised their price target on shares of MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a research report on Monday, April 15th. Piper Sandler upped their price objective on shares of MetLife from $74.00 to $85.00 and gave the stock an “overweight” rating in a research report on Friday, April 5th. The Goldman Sachs Group raised shares of MetLife from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $70.00 to $80.00 in a research report on Monday, January 8th. Finally, Wells Fargo & Company upped their target price on MetLife from $83.00 to $86.00 and gave the company an “overweight” rating in a report on Thursday, April 11th.

Read Our Latest Stock Analysis on MET

Insider Buying and Selling at MetLife

In other news, EVP Bill Pappas sold 27,000 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the sale, the executive vice president now owns 57,768 shares of the company’s stock, valued at $4,174,893.36. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other MetLife news, insider Ramy Tadros sold 4,026 shares of the firm’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the transaction, the insider now owns 146,981 shares in the company, valued at approximately $10,567,933.90. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Bill Pappas sold 27,000 shares of the company’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the sale, the executive vice president now owns 57,768 shares in the company, valued at $4,174,893.36. The disclosure for this sale can be found here. Insiders own 0.32% of the company’s stock.

Hedge Funds Weigh In On MetLife

A number of large investors have recently modified their holdings of MET. CNB Bank grew its position in shares of MetLife by 9.3% during the 1st quarter. CNB Bank now owns 1,735 shares of the financial services provider’s stock valued at $129,000 after purchasing an additional 147 shares in the last quarter. Strategic Blueprint LLC lifted its stake in MetLife by 2.9% in the first quarter. Strategic Blueprint LLC now owns 5,323 shares of the financial services provider’s stock worth $394,000 after purchasing an additional 151 shares during the last quarter. Marcum Wealth LLC increased its holdings in shares of MetLife by 4.7% in the first quarter. Marcum Wealth LLC now owns 3,436 shares of the financial services provider’s stock worth $255,000 after buying an additional 153 shares during the period. GoalVest Advisory LLC boosted its holdings in MetLife by 73.3% during the 1st quarter. GoalVest Advisory LLC now owns 390 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 165 shares during the period. Finally, SWS Partners increased its stake in MetLife by 0.3% in the 1st quarter. SWS Partners now owns 55,356 shares of the financial services provider’s stock worth $4,102,000 after purchasing an additional 165 shares during the period. 89.81% of the stock is currently owned by institutional investors.

MetLife Stock Performance

NYSE MET opened at $70.23 on Friday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.53. The company has a fifty day simple moving average of $71.64 and a 200 day simple moving average of $67.40. MetLife has a 12-month low of $48.95 and a 12-month high of $74.68. The company has a market cap of $50.08 billion, a P/E ratio of 38.38, a PEG ratio of 0.53 and a beta of 1.03.

MetLife (NYSE:METGet Free Report) last posted its earnings results on Wednesday, May 1st. The financial services provider reported $1.83 EPS for the quarter, hitting the consensus estimate of $1.83. The company had revenue of $17.02 billion during the quarter, compared to the consensus estimate of $17.73 billion. MetLife had a net margin of 2.36% and a return on equity of 19.48%. The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.52 earnings per share. Sell-side analysts predict that MetLife will post 8.71 earnings per share for the current fiscal year.

MetLife Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 11th. Stockholders of record on Tuesday, May 7th will be paid a dividend of $0.545 per share. This is an increase from MetLife’s previous quarterly dividend of $0.52. The ex-dividend date is Monday, May 6th. This represents a $2.18 annualized dividend and a dividend yield of 3.10%. MetLife’s dividend payout ratio is presently 113.66%.

MetLife announced that its Board of Directors has initiated a share buyback plan on Wednesday, May 1st that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to repurchase up to 6% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board believes its stock is undervalued.

MetLife Company Profile

(Get Free Report

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.